Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 11% – Here’s What Happened

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK)’s stock price traded up 11% during trading on Tuesday . The stock traded as high as $84.00 and last traded at $79.50. 44,958 shares traded hands during mid-day trading, a decline of 56% from the average session volume of 102,480 shares. The stock had previously closed at $71.63.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aimei Health Technology currently has a consensus rating of “Sell”.

Aimei Health Technology Stock Performance

The stock has a market cap of $472.77 million, a price-to-earnings ratio of 367.87 and a beta of -3.70. The company’s 50 day simple moving average is $26.43 and its two-hundred day simple moving average is $16.60.

Aimei Health Technology (NASDAQ:AFJK) last posted its quarterly earnings results on Tuesday, November 18th. The company reported $0.06 EPS for the quarter.

Institutional Investors Weigh In On Aimei Health Technology

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Wellspring Financial Advisors LLC acquired a new stake in shares of Aimei Health Technology during the 2nd quarter valued at about $133,000. Clear Street LLC grew its position in Aimei Health Technology by 63.8% in the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock worth $441,000 after acquiring an additional 15,399 shares in the last quarter. Clear Street Group Inc. acquired a new position in shares of Aimei Health Technology during the 3rd quarter worth $691,000. Quarry LP raised its holdings in shares of Aimei Health Technology by 6.4% during the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Crossingbridge Advisors LLC bought a new position in shares of Aimei Health Technology during the 2nd quarter valued at $2,147,000. 45.58% of the stock is owned by hedge funds and other institutional investors.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.